Contenu disponible en anglais seulement.
Bulletin de la Bourse
Dialogue Health Technologies Inc. (CARE) inscrit à la Bourse de Toronto
26 mars 2021
| Issuer: | Dialogue Health Technologies Inc. (the "Company") |
| Security: | Common shares (the "Common Shares") |
| Symbols: | CARE |
| Issue price per security: | $12.00 |
| Number of securities issued and outstanding: | 64,878,039 |
| Number of securities reserved for issuance: | 10,310,900 |
| Listing category: | Industrial, Non Exempt |
| Trading currencies: | CDN$ |
| Transaction: | Initial public offering of Common Shares (the "Offering") |
| Listing date: | March 29, 2021 (as at 5:01 p.m.) in anticipation of closing of the Offering |
| Anticipated closing date: | March 30, 2021 (prior to the opening) |
| Posted for trading date: | March 30, 2021 (at the opening) subject to confirmation of closing of the Offering |
| Other market(s): | None |
| Temporary market maker: | RBC Capital Markets |
| Security ownership registration: | Certificated Issue |
| Investor relations: | Navaid Mansuri, Chief Financial Officer (438) 940-2635 Email: investors@dialogue.co - or - Nathalie Delisle, General Counsel (438) 940-2635 Email: investors@dialogue.co |
| Incorporation: | Canada Business Corporations Act |
| Fiscal year end: | December 31 |
| Nature of business: | The Company is a virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. |
| Transfer agent and registrar: | Computershare Investor Services Inc. at its principal offices in Montréal and Toronto |
| Dividends: | The Company currently intends to retain any future earnings to fund the development and growth of its business and does not currently anticipate paying dividends on its Common Shares. Any determination to pay dividends in the future will be at the discretion of the Board and will depend on many factors, including, among others, its financial condition, its then current and anticipated cash requirements, contractual restrictions and financing agreement covenants, solvency tests imposed by applicable corporate law and other factors that the Board may deem relevant. |
| Sponsorship: | Waived |
| Disclosure document: | Final prospectus dated March 23, 2021, which is available at . Capitalized terms not otherwise defined herein are as defined in the disclosure document. |
| Initial public offering: | The Offering is comprised of 8,334,000 Common Shares issued from treasury being offered to the public at a price of $12.00 per Common Share (the "Offering Price") for total gross proceeds of $100,008,000 to the Company. In addition, the Selling Shareholders have granted an over-allotment option pursuant to which the Underwriters may purchase up to an additional 1,250,100 Common Shares at the Offering Price. The syndicate of Underwriters is comprised of National Bank Financial Inc., RBC Dominion Securities Inc., Scotia Capital Inc., TD Securities Inc., CIBC World Markets Inc., Desjardins Securities Inc., Canaccord Genuity Corp., iA Private Wealth Inc., INFOR Financial Inc. and Laurentian Bank Securities Inc. |
| TSX contact: | Chris Birkett, Managing Director, ÍÃ×ÓÏÈÉú |